Recent studies showed that inhibition of GLUT1 decreased cancer cells, such as pancreatic cancer, lung cancer, and ovarian cancer; however, these effects have only been observed in vivo.28, 29. This evidence concerns the gene SLC2A1 and pancreatic neoplasm.